Beijing Zhongke Xuekang Hematology Medical Research Institute, referred to as Beijing Hematology Research Institute, is a scientific research institution with distinctive traditional Chinese medicine characteristics that specializes in the study of blood diseases. It mainly produces and develops traditional Chinese medicine formulas. In 2010, it launched Clinical scientific research data and clinical rehabilitation cases, such as the State Intellectual Property Office's application for a drug patent, which was officially issued a patent drug certificate in 2011, and successfully developed a drug for blood diseases (thrombocytopenia, thrombocytosis, Henoch-Sch?nlein purpura, leukemia, aplastic anemia , myelodysplastic syndrome, polycythemia vera, and multiple myeloma).
The patent holders are Shi Shurong, Xie Bielu, Hu Guisheng, Zhan Wenyan, Hu Junfeng, and Liao Zuoqin.
Because the Beijing Institute of Hematology and Medicine is a scientific research institution, it has three cooperative medical campuses as designated units for clinical diagnosis, including one in Daxing District, one in Fengtai District, and one in Xicheng District.
The branch clinics are located in Daxing District, Fengtai District and Xicheng District. Local citizens should arrange their time accordingly and go to the nearest branch for consultation.